Erlanger Health projects $1 billion in revenue by 2019

Chattanooga, Tennessee-based Erlanger Health System expects to top $1 billion in annual revenues by 2019, with patient admission projected to increase by 10 percent in the next fiscal year and no signs of that rapid growth slowing down.

According to the Chattanooga Times Free Press, the hospital system’s revenue will have grown by 51 percent over five years by the end of fiscal year 2018.

“This is organic growth, not through mergers or acquisitions," said Erlanger CFO Britt Tabor. “Our top-line growth is helping us to make investments in new technology and quality improvements. It is a very challenging budget, but we think it is doable and a good investment for our future.”

Some members of the system’s budget committee are concerned about such rapid expansion, wondering whether it’s too much, too soon. Read the full article at the link below: 

""
John Gregory, Senior Writer

John joined TriMed in 2016, focusing on healthcare policy and regulation. After graduating from Columbia College Chicago, he worked at FM News Chicago and Rivet News Radio, and worked on the state government and politics beat for the Illinois Radio Network. Outside of work, you may find him adding to his never-ending graphic novel collection.

Around the web

The tirzepatide shortage that first began in 2022 has been resolved. Drug companies distributing compounded versions of the popular drug now have two to three more months to distribute their remaining supply.

The 24 members of the House Task Force on AI—12 reps from each party—have posted a 253-page report detailing their bipartisan vision for encouraging innovation while minimizing risks. 

Merck sent Hansoh Pharma, a Chinese biopharmaceutical company, an upfront payment of $112 million to license a new investigational GLP-1 receptor agonist. There could be many more payments to come if certain milestones are met.